A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease

Cited by (351)

Items 101–200 of 351

1. Chalcone-Based Carbamates for Alzheimer’S Disease Treatment
   Angela Rampa, Serena Montanari, Letizia Pruccoli, Manuela Bartolini, Federico Falchi, Alessandra Feoli, Andrea Cavalli, Federica Belluti, Silvia Gobbi, Andrea Tarozzi et al. · 2017 · Future Medicinal Chemistry
2. An evaluation of neonicotinoids' potential to inhibit human cholinesterases: Protein–ligand docking and interaction profiling studies
   Kerem Teralı · 2018 · Journal of Molecular Graphics and Modelling
3. Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases
   Vishnu Mini Sasi, Pavankumar Vangavolu, Sandeep Kumar, A. S. Raja · 2019 · ChemMedChem
4. Screening for Chemical Characterization and Pharmacological Properties of Different Extracts from Nepeta italica
   Alessandra Acquaviva, Simonetta Cristina Di Simone, Nilofar Nilofar, Abdelhakim Bouyahya, Gökhan Zengin, Lucia Recinella, Sheila Leone, Luigi Brunetti, Abdullahi İbrahim Uba, Osman Güler et al. · 2023 · Plants
5. Ethyl acetate leaf fraction of Cnidoscolus aconitifolius (Mill.) I. M. Johnst: antioxidant potential, inhibitory activities of key enzymes on carbohydrate metabolism, cholinergic, monoaminergic, purinergic, and chemical fingerprinting
   Basiru Olaitan Ajiboye, Oluwafemi Adeleke Ojo, Mary Abiola Okesola, Babatunji Emmanuel Oyinloye, Abidemi Paul Kappo · 2018 · International Journal of Food Properties
6. Synthesis, Biological Evaluation and Molecular Modelling of 2′-Hydroxychalcones as Acetylcholinesterase Inhibitors
   Sri Devi Sukumaran, Chin Fei Chee, Geetha Viswanathan, Michael J. C. Buckle, Rozana Othman, Noorsaadah Abd Rahman, Lip Yong Chung · 2016 · Molecules
7. Comparative studies on endogenic stress hormones, antioxidant, biochemical and hematological status of metabolic disturbance in albino rat exposed to roundup herbicide and its active ingredient glyphosate
   Folarin Ojo Owagboriaye, Gabriel Adewunmi Dedeke, Kehinde Olutoyin Ademolu, Olanrewaju Olusoji Olujimi, Adeyinka Adedeji Aladesida, Mistura Temitope Adeleke · 2019 · Environmental Science and Pollution Research
8. Combination of donepezil and gallic acid improves antioxidant status and cholinesterases activity in aluminum chloride-induced neurotoxicity in Wistar rats
   Tajudeen Olabisi Obafemi, Olutunmise Victoria Owolabi, Benjamin Olusola Omiyale, Blessing Augustine Afolabi, Oluwafemi Adeleke Ojo, A. Onasanya, Isaac Adekola Adu, Damilare Emmanuel Rotimi · 2021 · Metabolic Brain Disease
9. Synthesis and acetylcholinesterase enzyme inhibitory effects of some novel 4,5-Dihydro-1H-1,2,4-triazol-5-one derivatives; an in vitro and in silico study
   Hilal Medetalibeyoğlu, Fikret Türkan, Sevda Manap, Ercan Bursal, Murat Beytur, Abdülmelik Aras, Onur Akyıldırım, Gül Kotan, Özlem Gürsoy Kol, Haydar Yüksek · 2022 · Journal of Biomolecular Structure and Dynamics
10. Imidacloprid-based commercial pesticide causes behavioral, biochemical, and hematological impairments in Wistar rats
    Bruna Ducatti Tonietto, Ana Olívia Martins Laurentino, Marina Tuerlinckx Costa Valle, Larissa Vivan Cestonaro, Bibiana Pereira Antunes, Cleofas Sates, Nícolas Guimarães dos Santos, Eliane Dallegrave, Solange Cristina García, Mirna Bainy Leal et al. · 2022 · Environmental Toxicology and Pharmacology
11. Antioxidant activity and cholinesterase inhibition studies of four flavouring herbs from Alentejo
    Sílvia Arantes, Andreia Piçarra, Fátima Candeias, Dora Martins Teixeira, Ana Teresa Caldeira, M. Rosário Martins · 2017 · Natural Product Research
12. Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer’s Disease
    Eliška Kohelová, Rozálie Peřinová, Negar Maafi, Jan Korábečný, Daniela Hulcová, Jana Maříková, Tomáš Kučera, Loreto Martínez‐González, Martina Hrabinová, Katarína Vorčáková et al. · 2019 · Molecules
13. Conjugation of Aminoadamantane and γ-Carboline Pharmacophores Gives Rise to Unexpected Properties of Multifunctional Ligands
    Сергей Олегович Бачурин, Галина Ф. Махаева, E. F. Shevtsova, Aleksey Yu. Aksinenko, Vladimir V. Grigoriev, Pavel N. Shevtsov, Т. В. Горева, Т. А. Епишина, Надежда Владимировна Ковалева, Elena A. Pushkareva et al. · 2021 · Molecules
14. Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
    Magdalena Markowicz-Piasecka, Kristiina M. Huttunen, Joanna Sikora · 2018 · Journal of Enzyme Inhibition and Medicinal Chemistry
15. Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase
    Jana Maříková, Aneta Ritomská, Jan Korábečný, Rozálie Peřinová, Abdullah Al Mamun, Tomáš Kučera, Eliška Kohelová, Daniela Hulcová, Tereza Kobrlová, Jiřı́ Kuneš et al. · 2020 · Journal of Natural Products
16. Cholinesterase inhibitory activity, antioxidant properties, and phytochemical composition ofChlorococcumsp. extracts
    Tosin Abiola Olasehinde, Ademola Olufolahan Olaniran, Anthony Ifeanyi Okoh · 2020 · Journal of Food Biochemistry
17. Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau
    Tomasz Wichur, Anna Pasieka, Justyna Godyń, Dawid Panek, Izabella Góral, Gniewomir Latacz, Ewelina Honkisz-Orzechowska, Adam Bucki, Agata Siwek, Monika Głuch‐Lutwin et al. · 2021 · European Journal of Medicinal Chemistry
18. Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease
    Aliki Drakontaeidi, Eleni A. Pontiki · 2024 · International Journal of Molecular Sciences
19. Nature-based molecules combined with rivastigmine: A symbiotic approach for the synthesis of new agents against Alzheimer's disease
    Giulia Nesi, Qiuhe Chen, Simona Sestito, Maria Digiacomo, Xiaohong Yang, Shengnan Wang, Rongbiao Pi, Simona Rapposelli · 2017 · European Journal of Medicinal Chemistry
20. Multi-targeted ChEI-copper chelating molecules as neuroprotective agents
    Simona Sestito, Shengnan Wang, Qiuhe Chen, Junfeng Lu, Simone Bertini, Christian Silvio Pomelli, Grazia Chiellini, Xixin He, Rongbiao Pi, Simona Rapposelli · 2019 · European Journal of Medicinal Chemistry
21. Flow-through enzyme immobilized amperometric detector for the rapid screening of acetylcholinesterase inhibitors by flow injection analysis
    Marie Vandeput, Cobra Parsajoo, Jérôme Vanheuverzwijn, Stéphanie Patris, Yavuz Yardım, Alexandre le Jeune, Ahmad Sarakbi, Dominique Mertens, Jean‐Michel Kauffmann · 2014 · Journal of Pharmaceutical and Biomedical Analysis
22. In Silico Design of Dual-Binding Site Anti-Cholinesterase Phytochemical Heterodimers as Treatment Options for Alzheimer’s Disease
    Hafsa Amat-ur-Rasool, Mehboob Ahmed, Shahida Hasnain, Abrar Ahmed, Wayne Grant Carter · 2021 · Current Issues in Molecular Biology
23. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer’s Activity Profile
    Галина Ф. Махаева, Надежда Владимировна Ковалева, Natalia P. Boltneva, Елена Владимировна Рудакова, Sofya V. Lushchekina, T. Yu. Astakhova, Igor V. Serkov, Alexey N. Proshin, Eugene V. Radchenko, Vladimir A. Palyulin et al. · 2022 · Molecules
24. Indene-Derived Hydrazides Targeting Acetylcholinesterase Enzyme in Alzheimer’s: Design, Synthesis, and Biological Evaluation
    Shraddha Manish Gupta, Ashok Behera, Neetesh Kumar Jain, Devendra Kumar, Avanish Tripathi, Shailesh Mani Tripathi, Somdutt Mujwar, Jeevan Patra, Arvind Negi · 2022 · Pharmaceutics
25. Assessment of the effect of gasoline fume on stress hormones, antioxidant status and lipid peroxidation in albino rat
    Folarin Ojo Owagboriaye, Gabriel Adewunmi Dedeke, Adeyinka Adedeji Aladesida, Julius Akolawole Bamidele, Wasiu Eniola Olooto · 2016 · Journal of King Saud University - Science
26. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors
    Marek Bajda, Kamil Łątka, Michalina Hebda, Jakub Jończyk, Barbara Malawska · 2018 · Bioorganic Chemistry
27. Bergenia pacumbis from Nepal, an astonishing enzymes inhibitor
    Bishnu Prasad Pandey, Suman Prakash Pradhan, Kapil Adhikari, Saroj Nepal · 2020 · BMC Complementary Medicine and Therapies
28. The Genus Nerine Herb. (Amaryllidaceae): Ethnobotany, Phytochemistry, and Biological Activity
    Lucie Cahlíková, Nina Vaněčková, Marcela Šafratová, Katerina Hradiska Breiterova, Gerald Blunden, Daniela Hulcová, Lubomı́r Opletal · 2019 · Molecules
29. Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer’s Treatment: A Computational Strategy
    Nasimudeen R. Jabir, Md Tabish Rehman, Shams S. M. Tabrez, Raed F. Alserihi, Mohamed Fahad Alajmi, Mohd Shahnawaz Khan, Fohad Mabood Husain, Abdul Bakrudeen Ali Ahmed · 2021 · Current Pharmaceutical Design
30. Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease
    Saira Naseem, Ahmed Temirak, Aqeel Imran, Saquib Jalil, Shamool Fatima, Parham Taslımı, Jamshed Iqbal, Mussarat Tasleem, Muhammad Nawaz Tahir, Zahid Shafiq · 2023 · RSC Advances
31. Neuroprotective, neurite enhancing, and cholinesterase inhibitory effects of Lamiaceae family essential oils in Alzheimer’s disease model
    Win Ning Chen, Kar Wei Chin, Kim San Tang, Snežana Agatonović-Kuštrin, Keng Yoon Yeong · 2023 · Journal of Herbal Medicine
32. A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety
    Edgar Sawatzky, Ehab Al‐Momani, Ryohei Kobayashi, Takahiro Higuchi, Samuel Samnick, Michael W. Decker · 2016 · ChemMedChem
33. Cholinergic depletion and basal forebrain volume in primary progressive aphasia
    J. Schaeverbeke, C. Evenepoel, R. Bruffaerts, K. van Laere, G. Bormans, Eva Dries, T. Tousseyn, N. Nelissen, R. Peeters, M. Vandenbulcke et al. · 2016 · NeuroImage: Clinical
34. Interactions between Ginkgo biloba L. and Scutellaria baicalensis Georgi in multicomponent mixtures towards cholinesterase inhibition and ROS scavenging
    Delerue, Teresa, Fátima Barroso, M., Dias-Teixeira, Mónica, Figueiredo-González, Maria, Delerue-Matos, Cristina, Grosso, Clara · 2021 · Food Research International
35. Phenyldiazenyl-phenoxy-1,2,3-triazol-acetamide derivatives as new dual cholinesterase Inhibitors: Design, synthesis, in vitro, and in silico enzymatic inhibition evaluations
    Samira Zareei, Maryam Mohammadi‐Khanaposhtani, Mostafa Shahali, Halil Şenol, Mehran Badbedast, Ali Moazzam, Shahrzad Mohseni, Ensieh Nasli‐Esfahani, Sultan Funda Ekti, Bagher Larijani et al. · 2024 · Journal of Molecular Structure
36. Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines
    Krzysztof Lodarski, Jakub Jończyk, Natalia Szałaj, Marek Bajda, Joanna Gładysz, Joanna Walczyk, Małgorzata Jeleń, BEATA IZABELA MORAK-MŁODAWSKA, Krystian Pluta, Barbara Malawska · 2014 · Journal of Enzyme Inhibition and Medicinal Chemistry
37. Pharmacodynamics of Cholinesterase Inhibitors Suggests Add-on Therapy with a Low-Dose Carbamylating Inhibitor in Patients on Long-Term Treatment with Rapidly Reversible Inhibitors
    Taher Darreh‐Shori, Sh Makvand Hosseini, Agneta K. Nordberg · 2014 · Journal of Alzheimer s Disease
38. Highly efficient, catalyst-free, one-pot sequential four-component synthesis of novel spiroindolinone-pyrazole scaffolds as anti-Alzheimer agents: in silico study and biological screening
    Hormoz Pourtaher, Yasaman Mohammadi, Alireza Hasaninejad, Aida Iraji · 2023 · RSC Medicinal Chemistry
39. Proline-Based Carbamates as Cholinesterase Inhibitors
    Hana Pížová, M Havelková, Pavel Bobáľ, Šárka Štěpánková, Tereza Kauerová, Andrzej Bąk, Péter Kollár, Violetta Kozik, Michal Oravec, Aleš Imramovský et al. · 2017 · Molecules
40. Turning Donepezil into a Multi‐Target‐Directed Ligand through a Merging Strategy
    Rosaria Carmela Perone, Claudia Albertini, Elisa Uliassi, Flaminia Di Pietri, Pedro de Sena Murteira Pinheiro, Sabrina Petralla, Nicola Rizzardi, Romana Fato, Lenka Pulkrabkova, Ondřej Soukup et al. · 2020 · ChemMedChem
41. Synthesis and biological evaluation of 2′-Aminochalcone: A multi-target approach to find drug candidates to treat Alzheimer’s disease
    Renata P. Sakata, Giorgio Antoniolli, Marcelo Lancellotti, Daniel Fábio Kawano, Euzébio Guimarães Barbosa, Wanda P. Almeida · 2020 · Bioorganic Chemistry
42. Highly selective carbamate-based butyrylcholinesterase inhibitors derived from a naturally occurring pyranoisoflavone
    Chuanhai Wu, Yanbei Tu, Ziyuan Li, Yanfang Li · 2019 · Bioorganic Chemistry
43. The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic Source
    Khoshnur Jannat, Rengasamy Balakrishnan, Jun‐Hyuk Han, Ye-Ji Yu, Ga-Won Kim, Dong‐Kug Choi · 2023 · Cells
44. Design, synthesis, structure activity relationship and molecular docking studies of thiophene-2-carboxamide Schiff base derivatives of benzohydrazide as novel acetylcholinesterase and butyrylcholinesterase inhibitors
    Naghmana Kausar, Shahzad Murtaza, Muhammad Nadeem Arshad, Rubina Munir, Rahman Shah Zaib Saleem, Hummera Rafique, Abdul Tawab · 2021 · Journal of Molecular Structure
45. Exploration of synthetic multifunctional amides as new therapeutic agents for Alzheimer's disease through enzyme inhibition, chemoinformatic properties, molecular docking and dynamic simulation insights
    Mubashir Hassan, Muhammad Athar Abbasi, Aziz-ur- Rehman, Sabahat Zahra Siddiqui, Ghulam Hussain, Syed Adnan Alı Shah, Muhammad Abdul Rehman Shahid, Sung‐Yum Seo · 2018 · Journal of Theoretical Biology
46. Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE
    Pratibha Magar, Oscar Parravicini, Šárka Štěpánková, Katarína Svrčková, Adriana Garro, Izabela Jendrzejewska, Karel Pauk, Jan Hošek, Josef Jampílek, Ricardo Daniel Enriz et al. · 2021 · International Journal of Molecular Sciences
47. New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation
    Mohammed Salah Ayoup, Mariam Ghanem, Hamida Abdel‐Hamid, Marwa Muhammad Abu-Serie, Aliaa A. Masoud, Doaa Ahmad Ghareeb, Mohammed B. Hawsawi, Amr Sayed Motawi Sonousi, Asmaa E. Kassab · 2024 · BMC Chemistry
48. Inhibitory effect of ethyl acetate fraction ofSolanum macrocarponL. leaves on cholinergic, monoaminergic, and purinergic enzyme activities
    Basiru Olaitan Ajiboye, Maureen Chidima Akalabu, Oluwafemi Adeleke Ojo, Olakunle Bamikole Afolabi, Mary Abiola Okesola, Israel Olayide, Babatunji Emmanuel Oyinloye · 2018 · Journal of Food Biochemistry
49. Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24‐week, Randomized, Double‐Blind Parallel‐Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)
    Zhenxin Zhang, Zhen Hong, Yanping Wang, Li He, Ning Wang, Zhongxin Zhao, Gang Zhao, Lan Shang, Marianne Weisskopf, Francesca Callegari et al. · 2016 · CNS Neuroscience & Therapeutics
50. Synthesis, molecular docking, and biological evaluation of novel 2-pyrazoline derivatives as multifunctional agents for the treatment of Alzheimer's disease
    Oya Ünsal Tan, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, Ayla Balkan, Keriman Ozadali‐Sari · 2019 · MedChemComm
51. Amaryllidaceae alkaloids from Hippeastrum X Hybridum CV. Ferrari, and preparation of vittatine derivatives as potential ligands for Alzheimer´s disease
    Latifah A. Al Shammari, Daniela Hulcová, Jana Maříková, T. Kučera, Marcela Šafratová, Lucie Nováková, Monika Schmidt, Lenka Pulkrabkova, Jiří Janoušek, Ondřej Soukup et al. · 2020 · South African Journal of Botany
52. Recent developments in the design and synthesis of benzylpyridinium salts: Mimicking donepezil hydrochloride in the treatment of Alzheimer’s disease
    Saghi Sepehri, Mina Saeedi, Bagher A. Larijani, Mohammad Reza Mahdavi · 2022 · Frontiers in Chemistry
53. Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration
    Debasis Sen, Sunny Rathee, Vishal Pandey, Sanjay Jain, Umesh Kumar Patil · 2024 · Current Alzheimer Research
54. Increased Endogenous GDNF in Mice Protects Against Age-Related Decline in Neuronal Cholinergic Markers
    Sumonto Mitra, Giorgio Turconi, Taher Darreh‐Shori, Kärt Mätlik, Matilde Aquilino, Maria Eriksdotter, Jaan‐Olle Andressoo · 2021 · Frontiers in Aging Neuroscience
55. Molecular mechanisms of Alzheimer’s disease: From therapeutic targets to promising drugs
    Alan, Elif, Kerry, Zeliha, Sevin, Gulnur · 2023 · Fundamental & Clinical Pharmacology
56. RETRACTED ARTICLE: Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer’s Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway
    Hasan, Noorul, Zameer, Saima, Najmi, Abul Kalam, Parvez, Suhel, Akhtar, Mohd · 2022 · Neurotoxicity Research · Retracted
57. Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors
    Ana I. Ahuja‐Casarín, Penélope Merino‐Montiel, José Luis Vega-Báez, Sara Montiel‐Smith, Miguel X. Fernandes, Irene Lagunes, Inés Maya, José M. Padrón, Óscar López, José G. Fernández‐Bolaños · 2020 · Journal of Enzyme Inhibition and Medicinal Chemistry
58. Central Administration of Ampelopsin A Isolated from Vitis vinifera Ameliorates Cognitive and Memory Function in a Scopolamine-Induced Dementia Model
    Yuni Hong, Yun‐Hyeok Choi, Young‐Eun Han, Soo‐Jin Oh, Ansoo Lee, Bonggi Lee, Rebecca Magnan, Shi Yong Ryu, Chun Whan Choi, Min Soo Kim · 2021 · Antioxidants
59. Pharmacophore based virtual screening of cholinesterase inhibitors: search of new potential drug candidates as antialzheimer agents
    Nisha Lakra, Balaji Wamanrao Matore, Purusottam Banjare, Rekha K. Singh, Jagadish Singh, Partha Pratim Roy · 2022 · In Silico Pharmacology
60. Biomedical and therapeutic potential of marine-derived Pseudomonas sp. strain AHG22 exopolysaccharide: A novel bioactive microbial metabolite
    Ghfren S. Aloraini, Mona Othman I. Albureikan, Aisha M. A. Shahlol, Taghreed Shamrani, Hussam Daghistani, Mohammad El-Nablaway, Nagwa A. Tharwat, Ahmed M. Elazzazy, Ahmed Farouk Basyony, Ahmed Ghareeb · 2024 · REVIEWS ON ADVANCED MATERIALS SCIENCE
61. Designing of promising medicinal scaffolds for Alzheimer’s disease through enzyme inhibition, lead optimization, molecular docking and dynamic simulation approaches
    Mubashir Hassan, Muhammad Athar Abbasi, Aziz‐ur‐Rehman, Sabahat Zahra Siddiqui, Saba Shahzadi, Hussain Raza, Ghulam Hussain, Syed Adnan Alı Shah, Muhammad Ashraf, Muhammad Shahid et al. · 2019 · Bioorganic Chemistry
62. Chromenone: An emerging scaffold in anti-Alzheimer drug discovery
    Uma Agarwal, Saroj Kumar Verma, Rajiv Kumar Tonk · 2024 · Bioorganic & Medicinal Chemistry Letters
63. Pursuing the Complexity of Alzheimer’s Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists
    Jan Konecny, Anna Misiachna, Martina Hrabinová, Lenka Pulkrabkova, Markéta Benková, Lukáš Prchal, Tomas Kucera, Tereza Kobrlová, Vladimír Finger, Marharyta Kolcheva et al. · 2020 · Biomolecules
64. Identification of plant-based multitargeted leads for Alzheimer's disease: In-vitro and in-vivo validation of Woodfordia fruticosa (L.) Kurz
    Rinky Raghuvanshi, Vijay Kumar Nuthakki, Lovedeep Singh, Bikarma Singh, Sonali S. Bharate, Rajbir Bhatti, Sandip B. Bharate · 2021 · Phytomedicine
65. Aminoadamantane conjugates with carbazole derivatives as potential multitarget agents for the treatment of Alzheimer’s disease. Effect of the spacer structure
    Галина Ф. Махаева, E. F. Shevtsova, Надежда Владимировна Ковалева, Елена Владимировна Рудакова, Неганова Маргарита Евгеньевна, L. G. Dubova, Pavel N. Shevtsov, Aleksey Yu. Aksinenko, Vladimir B. Sokolov, Сергей Олегович Бачурин · 2018 · Russian Chemical Bulletin
66. New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes
    Maryam Mohammadi‐Khanaposhtani, Milad Noori, Yousef Valizadeh, Shahrzad Javanshir, Navid Dastyafteh, Ali Moaazam, Samanesadat Hosseini, Bagher A. Larijani, Hossein Adibi, Mahmood Biglar et al. · 2022 · Archiv der Pharmazie
67. Combining Deep Learning and Structural Modeling to Identify Potential Acetylcholinesterase Inhibitors from Hericium erinaceus
    Thana Sutthibutpong, Kewalin Posansee, Monrudee Liangruksa, Teerasit Termsaithong, Supanida Piyayotai, Paripok Phitsuwan, Patchreenart Saparpakorn, Supa Hannongbua, Teeraphan Laomettachit · 2024 · ACS Omega
68. Novel conjugates of tacrine with 1,2,4,-thiadiazole as highly effective cholinesterase inhibitors, blockers of NMDA receptors, and antioxidants
    Галина Ф. Махаева, Vladimir V. Grigoriev, Alexey N. Proshin, Надежда Владимировна Ковалева, Елена Владимировна Рудакова, Natalia P. Boltneva, Igor V. Serkov, Сергей Олегович Бачурин · 2017 · Doklady Biochemistry and Biophysics
69. Molecular Dynamics Revealing a Detour-Forward Release Mechanism of Tacrine: Implication for the Specific Binding Characteristics in Butyrylcholinesterase
    Zhiyang Zhang, Fangfang Fan, Wen Luo, Yuan Zhao, Chaojie Wang · 2020 · Frontiers in Chemistry
70. Design and synthesis of garlic-related unsymmetrical thiosulfonates as potential Alzheimer’s disease therapeutics: In vitro and in silico study
    Kani Zilbeyaz, Aykut Öztekіn, Emine Gunbatar Kutluana · 2021 · Bioorganic & Medicinal Chemistry
71. 1,2,4-Thiadiazoles as promising multifunctional agents for treatment of neurodegenerative diseases
    Галина Ф. Махаева, Alexey N. Proshin, Natalia P. Boltneva, Елена Владимировна Рудакова, Надежда Владимировна Ковалева, Olga G. Serebryakova, Igor V. Serkov, Сергей Олегович Бачурин · 2016 · Russian Chemical Bulletin
72. Assessment of Anti-Alzheimer Pursuit of Jambolan Fruit Extract and/or Choline against AlCl3 Toxicity in Rats
    Zeinab Abdel Salam Hawash, Ensaf M. Yassien, Badriyah Shadid Alotaibi, Amira M. Elmoslemany, Mustafa Shukry · 2023 · Toxics
73. Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease
    Eva Mezeiová, Lukáš Prchal, Martina Hrabinová, Ľubica Múčková, Lenka Pulkrabkova, Ondřej Soukup, Anna Misiachna, Jiří Janoušek, Jakub Fibigar, Tomas Kucera et al. · 2024 · Biomedicine & Pharmacotherapy
74. Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE
    Jerneja Kladnik, Samuel Ristovski, Jakob Kljun, Andrea Defant, Ines Mancini, Kristina Sepčić, Iztok Turel · 2020 · International Journal of Molecular Sciences
75. A comparative assessment of biological activities of Gundelia dersim Miller and Gundelia glabra Vitek, Yüce & Ergin extracts and their chemical characterization via HPLC-ESI-TOF-MS
    María de la Luz Cádiz‐Gurrea, Gökhan Zengin, Francisco Javier Leyva‐Jiménez, Álvaro Fernández‐Ochoa, Kouadio Ibrahime Sinan, Uğur Çakılcıoğlu, Ebru Yüce Babacan, Mohamad Fawzi Mahomoodally, Marie Carene Nancy Picot-Allain, Jianbo Xiao et al. · 2020 · Process Biochemistry
76. Enhanced Recognition Memory through Dual Modulation of Brain Carbonic Anhydrases and Cholinesterases
    Alessio Nocentini, Alessia Costa, Alessandro Bonardi, Andrea Ammara, Simone Giovannuzzi, Andrea Petreni, Gianluca Bartolucci, Barbara Rani, Manuela Leri, Monica Bucciantini et al. · 2024 · Journal of Medicinal Chemistry
77. Functionalized aromatic esters of the Amaryllidaceae alkaloid haemanthamine and their in vitro and in silico biological activity connected to Alzheimer’s disease
    Rozálie Peřinová, Negar Maafi, Jan Korábečný, Eliška Kohelová, Angela De Simone, Abdullah Al Mamun, Daniela Hulcová, Jana Marková, Tomáš Kučera, Daniel Jun et al. · 2020 · Bioorganic Chemistry
78. Structure–activity relationship, in vitro and in vivo evaluation of novel dienyl sulphonyl fluorides as selective BuChE inhibitors for the treatment of Alzheimer's disease
    Chengyao Wu, Guijuan Zhang, Zai-Wei Zhang, Xia Jiang, Ziwen Zhang, Huanhuan Li, Hua‐Li Qin, Wenjian Tang · 2021 · Journal of Enzyme Inhibition and Medicinal Chemistry
79. Methoxy-naphthyl-Linked N ‑Benzyl Pyridinium Styryls as Dual Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Structure–Activity Relationship
    Mohd Abdullaha, Razia Banoo, Vijay Kumar Nuthakki, Mohit K. Sharma, Sukhleen Kaur, Shikha Thakur, Ajay Kumar, Hemant R. Jadhav, Sandip Bibishan Bharate · 2023 · ACS Omega
80. Anticholinesterase, antioxidant, analgesic and anti-inflammatory activity assessment ofXeranthemum annuumL. and isolation of two cyanogenic compounds
    İlkay Erdoğan Orhan, Fulya Gulyurdu, Esra Kupeli Akkol, Fatma Sezer Şenol, Serap Arabacı Anul, I. İrem Tatlı · 2016 · Pharmaceutical Biology
81. New biphenanthrenes with butyrylcholinesterase inhibitory activitiy from Cremastra appendiculata
    Liang Liu, Qi-Meng Yin, Qian Gao, Jun Li, Yong Jiang, Pengfei Tu · 2019 · Natural Product Research
82. Implications of the non‐neuronal cholinergic system for therapeutic interventions of inflammatory skin diseases
    Hui‐Qi Qu, Charlly Kao, Hakon H. Hakonarson · 2024 · Experimental Dermatology
83. Design and synthesis of new 1,2,3-triazole-methoxyphenyl-1,3,4-oxadiazole derivatives: selective butyrylcholinesterase inhibitors against Alzheimer’s disease
    Aida Iraji, Roshanak Hariri, Mohammad Hashem Hashempur, Mahsa Ghasemi, Hormoz Pourtaher, Mina Saeedi, Tahmineh Akbarzadeh · 2025 · BMC Chemistry
84. Huprine Y – Tryptophan heterodimers with potential implication to Alzheimer’s disease treatment
    Eva Mezeiová, Martina Hrabinová, Vendula Hepnarová, Daniel Jun, Jana Janočková, Ľubica Múčková, Lukáš Prchal, Zdena Krištofíková, Tomas Kucera, Lukáš Górecki et al. · 2021 · Bioorganic & Medicinal Chemistry Letters
85. Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways
    Thi Hanh Nguyen, San‐Lang Wang, Van Bon Nguyen · 2023 · Pharmaceuticals
86. Low Plasma Cholinesterase Activities are Associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer’s Disease
    Dominika Dingová, Tomáš Fazekaš, Petra Okuliarova, Jaroslava Strbova, Matej Kucera, Anna Hrabovská · 2016 · Journal of Alzheimer s Disease
87. Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer’s disease
    R Nieto, William James Deardorff, George Thomas Grossberg · 2016 · Expert Opinion on Pharmacotherapy
88. Evaluation of the inhibitory effect of abamectin on mammalian butyrylcholinesterase: Enzyme kinetic and molecular docking studies
    Kerem Teralı, Özlem Dalmızrak, Qendresa Hoti, Nazmi Özer · 2018 · Journal of Environmental Science and Health Part B
89. Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy
    Anaïs Barré, Rabah Azzouz, Vincent Gembus, Cyril A. Papamicaël, Vincent Levacher · 2019 · Molecules
90. 4-Oxobenzo[d]1,2,3-triazin-pyridinium-phenylacetamide derivatives as new anti-Alzheimer agents: design, synthesis, in vitro evaluation, molecular modeling, and molecular dynamic study
    Fahimeh Sadat Hosseini, Maryam Mohammadi‐Khanaposhtani, Homa Azizian, Ali Ramazani, Maliheh Barazandeh Tehrani, Hamid Nadri, Bagher A. Larijani, Mahmoud Biglar, Hossein Adibi, Mohammad Reza Mahdavi · 2020 · Structural Chemistry
91. Application of Green Technologies in Design-Based Extraction of Celastrus paniculatus (Jyotishmati) Seeds, SEM, GC-MS Analysis, and Evaluation for Memory Enhancing Potential
    Ashwani Arya, Deepak Kumar Kaushik, Rafa Almeer, SIMONA GABRIELA BUNGAU, Amany Ahmed Sayed, Mohamed M. Abdel‐Daim, Saurabh Bhatia, Vineet Mittal · 2022 · Frontiers in Nutrition
92. 1,2,4-Thiadiazole derivatives as effective NMDA receptor blockers with anticholinesterase activity and antioxidant properties
    Vladimir V. Grigoriev, Галина Ф. Махаева, Alexey N. Proshin, Надежда Владимировна Ковалева, Елена Владимировна Рудакова, Natalia P. Boltneva, A. V. Gabrel ́yan, B. V. Lednev, Сергей Олегович Бачурин · 2017 · Russian Chemical Bulletin
93. Dual anti-cholinesterase activity of ajoene by In silico and In vitro studies
    Suresh Kumar, Shivani Kumar, Sayan Chatterjee · 2018 · Pharmacognosy Research
94. Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
    Žofia Chrienová, Eugenie Nepovimová, Rudolf Andrýs, Rafael Doležal, Jana Janočková, Ľubica Múčková, Lenka Fabova, Ondřej Soukup, Patrik Olekšák, Martin Vališ et al. · 2022 · Journal of Enzyme Inhibition and Medicinal Chemistry
95. Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study
    Dang Xuan Du, Nguyen Huu Duy Khang, Nguyen Huu Tri, Pham Cam Nam, Nguyen Minh Thong · 2023 · ACS Omega
96. Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer’s Disease
    Saurabh G. Londhe, Vinayak S. Walhekar, Selanere S. Mangala, Suvarna G. Kini, Marcus Tullius Scotti, Luciana Scotti, Dileep Kumar · 2024 · Pharmaceutics
97. Exploring Novel Quinoline-1,3,4-Oxadiazole Derivatives for Alzheimer’s Disease: Their Design, Synthesis, and In-Vitro and In-Silico Investigations
    Sana Saffour, Asaf Evrim Evren, Begüm Nurpelin Sağlık, Leyla Yurttaş · 2024 · Current Medicinal Chemistry
98. Cellular stress response and neuroprotection of flavonoids in neurodegenerative diseases: Clinical insights into targeted therapy and molecular signaling pathways
    Biswajit Kumar Utpal, Baishakhi Sutradhar, Mehrukh Zehravi, Sherouk Hussein Sweilam, Trupti Pratik Durgawale, Uppuluri Varuna Naga Venkata Arjun, Thukani Sathanantham Shanmugarajan, Shruthi Paramasivam Kannan, P. Dharani Prasad, Md. Rageeb Md. Usman et al. · 2024 · Brain Research
99. Oxidation at C-16 enhances butyrylcholinesterase inhibition in lupane triterpenoids
    María Julia Castro, Victoria Richmond, María Belén Faraoni, Ana Paula Murray · 2018 · Bioorganic Chemistry
100. Vitamin B3-Based Biologically Active Compounds as Inhibitors of Human Cholinesterases
     Antonio Zandona, Gabriela Lihtar, Nikola Maraković, Katarina Miš, Valentina Bušić, Dajana Gašo-Sokač, Sergej Pirkmajer, Maja Katalinić · 2020 · International Journal of Molecular Sciences